Skip to main content

Tm Bioscience Mulls Possible Sale or Merger as Respiratory Panel Receives CE Mark

NEW YORK (GenomeWeb News) - Tm Bioscience today said it may be looking for a buyer or merger partner as one of several “strategic alternatives” it is exploring.
The company said it has formed a committee to look into its market potential and merger opportunities, although it added that it had not yet made any decisions to enter any transactions and that it will not list the names of potential partners.
Tm said it had recently received several inquiries and believes “this indication of interest demonstrates that it is an ideal time to explore our options.”
Company president and CEO Greg Hines said it is in the best interest of the company’s current and future customers that it finds such an alternative to help develop and promote its products.
Tm Bio said it has already retained the investment firms Leerink Swann & Co. of Boston and Westwind Partners of Toronto as financial advisors.
Separately, the company said its ID-Tag Respiratory Viral Panel has received CE Mark (Conformité Européene) status.
The company can now market the test for diagnostic purposes in countries following the European directives for viral testing.
Hines said the CE Mark approval for the ID-Tag RVP, which works to help physicians identify what virus may or may not be causing an illness, is integral to the company’s global marketing strategy.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.